review Open AccessTop 1% cited
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Annals of Oncology · 2008 · Vol. 19(9) · pp. 1523–1529
Cristina Grávalos✉(Research Institute Hospital 12 de Octubre)Antonio Jimeno(University of Colorado Cancer Center)
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins ResearchMedicineCancerOncologyClinical trialBreast cancerDiseaseInternal medicineTargeted therapyBioinformatics
MeSH terms
TrastuzumabAntibodies, MonoclonalAntineoplastic AgentsFemaleHumansMaleNeoplasm InvasivenessNeoplasm StagingPrognosisSensitivity and SpecificityStomach NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticSurvival AnalysisRandomized Controlled Trials as Topic
Citations
1,169
FWCI
16.16
field-weighted impact
References
72
Percentile
100%
vs. same field & year
Citations per year
Cited by
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
Oncotarget · 2016 · 1,061 citations
Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies
International Journal of Molecular Sciences · 2020 · 1,524 citations
Tumor targeting via EPR: Strategies to enhance patient responses
Advanced Drug Delivery Reviews · 2018 · 1,186 citations
Biomarkers of gastric cancer: Current topics and future perspective
World Journal of Gastroenterology · 2018 · 496 citations
References
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
Digestive Diseases and Sciences · 2006 · 325 citations
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
New England Journal of Medicine · 2006 · 6,297 citations
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
New England Journal of Medicine · 2001 · 11,439 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.